ID: ALA4590917

Max Phase: Preclinical

Molecular Formula: C12H14N2

Molecular Weight: 186.26

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1ccc2[nH]c3c(c2c1)CCNC3

Standard InChI:  InChI=1S/C12H14N2/c1-8-2-3-11-10(6-8)9-4-5-13-7-12(9)14-11/h2-3,6,13-14H,4-5,7H2,1H3

Standard InChI Key:  LYHQPJGFWRVZED-UHFFFAOYSA-N

Associated Targets(non-human)

pyrC Dihydroorotase (41 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 186.26Molecular Weight (Monoisotopic): 186.1157AlogP: 2.12#Rotatable Bonds: 0
Polar Surface Area: 27.82Molecular Species: BASEHBA: 1HBD: 2
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.09CX LogP: 2.10CX LogD: 0.42
Aromatic Rings: 2Heavy Atoms: 14QED Weighted: 0.65Np Likeness Score: -0.26

References

1. Rice AJ, Lei H, Santarsiero BD, Lee H, Johnson ME..  (2016)  Ca-asp bound X-ray structure and inhibition of Bacillus anthracis dihydroorotase (DHOase).,  24  (19): [PMID:27499369] [10.1016/j.bmc.2016.07.055]

Source